Loading
journalsJournal
Gut
aka Gut (BMJ), src-gut
Gut is the British Society of Gastroenterology's journal: pancreatic and gastrointestinal cancer surveillance guidelines, cohort and registry studies and the microbiome papers that the pancreatic and colorectal records cite.
Overview
Gut appears monthly and publishes the British Society of Gastroenterology's guidelines alongside international consensus statements such as the CAPS consortium's 2020 recommendations for surveillance of people at inherited risk of pancreatic cancer, population studies of pancreatic cysts (the SHIP MRCP cohort), the Dutch high-risk surveillance yield, and the colorectal screening and Barrett's surveillance literature. Hybrid access; guidelines are free to read. Added to the corpus by the pancreatic cancer review of 24 September 2026 because four of the pancreatic key papers are published in it.
Publisher
BMJ Group · British Society of Gastroenterology
Scope
gastroenterology and hepatology
Website
Access model
hybrid
Founded
1960
ISSN
0017-5749
guideline2023changed practice77 citations
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
For a UK patient with gallbladder cancer the nearest national guideline is about a neighbouring disease; the UK and NHS page for gallbladder cancer names the gap.
meta analysis2021211 citations
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
It tells the pathologist which pancreatic cancers to test for the one immunotherapy-responsive subgroup and how.
guideline2020changed practice472 citations
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
The rulebook behind the CAPS cohorts and the UK EUROPAC programme; it is also the reason surveillance for carriers is not yet a routine NHS service, because the consortium itself asked for it to stay within research until benefit was shown.
guideline2018changed practice976 citations
European evidence-based guidelines on pancreatic cystic neoplasms (2018)
European centres manage pancreatic cysts by this guideline; its lifelong surveillance stance is the main point of difference from the American and Kyoto guidelines.
translational2018107 citations
IPMNs with co-occurring invasive cancers: neighbours but not always relatives
Risk stratification of a cyst cannot assume the nearby cancer came from it, and the whole gland stays at risk after cyst resection.
Hassan Malik
Consultant Hepatobiliary Surgeon and Clinical Lead for Digestive Surgery, Liverpool University Hospitals (Aintree); Associate Professor, University of Liverpool
Hepatobiliary surgeryLiver resectionRetroperitoneal sarcoma
Liver surgeon at Aintree who co-wrote the BSG cholangiocarcinoma guideline and is a co-author of the UK-wide CAPBIL studies of gallbladder cancer surgery; a past president of the British Association of Surgical Oncology.
John Bridgewater
Professor of Medical Oncology, UCL Cancer Institute; Consultant Medical Oncologist, University College London Hospitals; Medical Adviser, AMMF
Biliary tract cancerCarcinoma of unknown primaryGastrointestinal oncology
Senior author of the UK's two standard-setting biliary trials, ABC-02 and BILCAP, chief investigator of ABC-06, and UK lead of the first-line precision medicine trial SAFIR-ABC10.
Shahid A. Khan
Professor of Practice (Hepatology), Imperial College London; Consultant Gastroenterologist and Hepatologist, Imperial College Healthcare NHS Trust; Chair, Cholangiocarcinoma-UK; Medical Adviser, AMMF
Cholangiocarcinoma epidemiologyHepatologyBiliary tract cancer guidelines
Hepatologist who documented the rise of cholangiocarcinoma in the UK and senior author of the 2023 British Society of Gastroenterology guideline that sets out how NHS teams should diagnose and manage it.
Notes
top- Holds: gastroenterology society guidelines, surveillance and screening cohorts, pancreatic precursor and cyst studies. Access: paywalled; guidelines free.
meta analysisGut 2021211 citations
Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications
It tells the pathologist which pancreatic cancers to test for the one immunotherapy-responsive subgroup and how.
guidelineGut 2020changed practice472 citations
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
The rulebook behind the CAPS cohorts and the UK EUROPAC programme; it is also the reason surveillance for carriers is not yet a routine NHS service, because the consortium itself asked for it to stay within research until benefit was shown.
translationalGut 2018107 citations
IPMNs with co-occurring invasive cancers: neighbours but not always relatives
Risk stratification of a cyst cannot assume the nearby cancer came from it, and the whole gland stays at risk after cyst resection.
Similar pages
not linked directly; found by shared links- TargetRNF43
Shares IPMNs with co-occurring invasive cancers: neighbours but not always relatives, Pancreatic ductal adenocarcinoma, Colorectal cancer.
- TargetGNAS
Shares IPMNs with co-occurring invasive cancers: neighbours but not always relatives, Pancreatic ductal adenocarcinoma, Colorectal cancer.
- PersonDiane M. Simeone
Shares Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium, Pancreatic ductal adenocarcinoma.
- TreatmentVENTANA MMR RxDx Panel
Shares Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications, Pancreatic ductal adenocarcinoma, Colorectal cancer.
- TechnologyMSI and mismatch-repair testing
Shares Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications, Pancreatic ductal adenocarcinoma, Colorectal cancer.
- TrialPRECEDE
Shares Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium, Pancreatic ductal adenocarcinoma.
- TermCAPS: the Cancer of the Pancreas Screening consortium and its surveillance studies (CAPS1 to CAPS5)
Shares Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium, Pancreatic ductal adenocarcinoma.
- Key paperRisk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
Shares Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium, Pancreatic ductal adenocarcinoma.
cancers
2key papers
3Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implicationsIPMNs with co-occurring invasive cancers: neighbours but not always relativesManagement of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium